Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
WJ-MSCs in Retinitis Pigmentosa
NCT04224207Phase 3Completed
- Sponsor
- Ankara Üniversitesi Teknokent
- Start
- Apr 2019
- Primary completion
- Oct 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of wharton's jelly mesenchymal stromal cells in retinitis pigmentosa (RP), sponsored by Ankara Üniversitesi Teknokent. Started Apr 2019; status: completed.
02
Drugs
wharton's jelly mesenchymal stromal cells
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT04224207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04224207.